Methylprednisolone Market size is forecast to reach $852.7 Million by 2025, growing at a CAGR of 3.21% during the forecast period 2020-2025. Methylprednisolone, sold under the brand name Depo-Medrol among others, is a corticosteroid medication and immunosuppressive drug used to suppress the immune system and decrease inflammation. Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Intravenous methylprednisolone (Solu-medrol) has been shown effective in the treatment of chemotherapy-induced nausea and vomiting.This medication is a corticosteroid hormone. Methylprednisolone is known to interact with drugs like indomethacin, carvedilol and enalapril, which in some cases turns out to provide side effects. Methylprednisolone can also be used with other medications in hormone disorders. Rapidly increasing chronic disorders among the growing geriatric population, increasing frequency of brain tumors and dermatological problems, rapid market developments by key market players and growing health awareness are driving the market growth in recent years. In addition, developments by market players like Oakrum Pharma are other factors driving the growth of the market.
North America dominated the Methylprednisolone Market in the year 2019, owing to the well-developed economy of the region, rising health care expenditure, increasing incidence of lifestyle-related diseases and increasing investments by key market players for better R&D activities. The Methylprednisolone Market scope for different regions will be provided in the final report.
Increasing prevalence of chronic diseases among a big quarter of the population, rising demand for topical corticosteroids, technological advancements in drug discovery process and rapid surge in investments for R&D activities and innovations in drugs by key market companies have helped in significant growth of Methylprednisolone Market.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Methylprednisolone Market report.
Stringent regulatory government policies for drug development is anticipated to hamper the market growth of the Methylprednisolone Industry.
Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=501966
Drivers – Methylprednisolone Market
Increasing prevalence of lifestyle related diseases
Technological advancements in drug discovery process
Methylprednisolone Market top 10 companies are Oakrum Pharma, Intelgenx Corp, Jubilant Cadista Pharmaceutical Inc, Pfizer Inc., Pharmacia, Sandoz, Teva Pharmaceutical, Tianjin Kingyork, Opko Health and Zhejiang Xianju Pharmaceutical Co.,Ltd. among others.
About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to email@example.com to discuss more about our consulting services.